Copley Acquisition Corp and Ignite Proteomics Announce Definitive Business Combination Agreement

Copley Acquisition Corp (NYSE: COPL), a special purpose acquisition company, and Ignite Proteomics, LLC, a company focused on precision oncology, have entered into a definitive business combination agreement. Upon closing, the combined entity will be named Ignite Proteomics Holdings, Inc. and is expected to be listed on the New York Stock Exchange.